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Abstract
Background: Mental illness is an escalating concern worldwide. The management of disorders such as anxiety and depression
largely falls to family doctors or general practitioners (GPs). However, GPs are often too time constrained and may lack the
necessary training to adequately manage the needs of such patients. Evidence-based Internet interventions represent a potentially
valuable resource to reduce the burden of care and the cost of managing mental health disorders within primary care settings and,
at the same time, improve patient outcomes.
Objective: The present study sought to extend the efficacy of a therapist-assisted Internet treatment program for panic disorder,
Panic Online, by determining whether comparable outcomes could be achieved and maintained when Panic Online was supported
by either GPs or psychologists.
Methods: Via a natural groups design, 96 people with a primary diagnosis of panic disorder (with or without agoraphobia)
completed the Panic Online program over 12 weeks with the therapeutic assistance of their GP (n = 53), who had received specialist
training in cognitive behavioral therapy, or a clinical psychologist (n = 43). Participants completed a clinical diagnostic telephone
interview, conducted by a psychologist, and a set of online questionnaires to assess panic-related symptoms at three time periods
(pretreatment, posttreatment, and 6 month follow-up).
Results: Both treatments led to clinically significant improvements on measures of panic and panic-related symptomatology
from pretreatment to posttreatment. Both groups were shown to significantly improve over time. Improvements for both groups
were maintained at follow-up; however, the groups did differ significantly on two quality of life domains: physical (F1,82 = 9.13,
P = .00) and environmental (F1,82 = 4.41, P = .04). The attrition rate was significantly higher among those being treated by their
GP (χ21 = 4.40, P = .02, N = 96).
Conclusions: This study provides evidence that Internet-based interventions are an effective adjunct to existing mental health
care systems. Consequently, this may facilitate and enhance the delivery of evidence-based mental health treatments to increasingly
large segments of the population via primary care systems and through suitably trained health professionals.
(J Med Internet Res 2008;10(2):e14)   doi:10.2196/jmir.1033
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Introduction
Projections indicate that by the year 2020 mental health and
neurological disorders will account for 15% of the global burden
of disease [1]. Such worldwide estimates are comparable in
Australia, with mental illness accounting for 13% of total disease
burden [2] and 1 in 10 Australian adults reporting that they
suffer from a long-term mental or behavioral problem [3].
Despite the high prevalence, up to 40% of people experiencing
a mental health problem do not receive any mental health care
within a given 12-month period [4]. Typically, when treatment
is sought, general practitioners (GPs) are the first, and often
only, point of contact [5,6], with a recent Australian national
survey finding that psychological problems account for 7.8%
of GP visits [7]. Seeking help from a GP confers a number of
advantages over other mental health professionals, such as
psychologists and psychiatrists, in that GP visits are more
accessible, affordable, and less stigmatizing [8].
In an attempt to address gaps in mental health care service
provision in Australia, and in recognition of the critical role
GPs play in service delivery, the government has expanded the
number of Medicare (Australia’s universal health care system)
rebate items for mental health consultations, and, in 2001,
introduced the Better Outcomes in Mental Health Care
(BOiMHC) initiative. The BOiMHC initiative includes
educational activities and financial incentives to improve the
capacity of GPs to deliver evidence-based psychological
interventions such as cognitive behavioral therapy (CBT) [9].
Although the initiative has been welcomed by the health industry
and consumers, difficulties in service provision remain. For
example, GPs often lack the time and necessary resources and
support mechanisms to deliver appropriate psychological
interventions to their patients, such as clinical supervision [10].
Consequently, not all GPs and/or regional divisions of general
practice choose to participate, thereby creating inequitable
patient access. As such, it is important to consider alternative
models of delivering effective, evidence-based therapy,
particularly for use in primary care. One promising and emerging
service delivery modality is the Internet.
Internet-Based Therapy
Internet-based therapy (eTherapy) typically involves the
interaction between a consumer and therapist (eTherapist) via
the Internet [11] and incorporates the use of a structured
Web-based treatment program for consumers to access in
conjunction with eTherapist assistance (usually by email) [12].
Approximately 84% of Australians have access to the Internet
[13]; consequently, eTherapy programs offer a unique
opportunity to deliver evidence-based mental health treatment,
without the need for intensive therapist involvement, to large
underserved segments of the population.
Over the past decade, Internet-based treatments have been found
effective for a variety of physical health conditions and mental
health disorders, such as headache [14], encopresis [15], tinnitus
[16], depression [17], and posttraumatic stress symptoms [18].
Based on existing research, the psychological disorder most
effectively treated via the Internet is one of the most common
anxiety disorders—panic disorder.
Panic Disorder
Panic disorder affects approximately 1.3% (with agoraphobia,
2.4%) of the Australian population annually [5]. It is
characterized by recurrent unexpected panic attacks and is
commonly associated with other anxiety disorders [6],
depression [19,20], increased risk of suicide [19], and substance
and alcohol abuse [20]. Its incidence among people attending
general practices has been estimated to be as high as 1 in 12
[21].
CBT is a well established and highly effective treatment for
panic disorder (with or without agoraphobia) [22]. The efficacy
of CBT for panic disorder appears uncompromised when patients
have comorbid depression [23] and when it is transferred from
controlled research settings to real-world clinical settings [24].
Although CBT is effective for people with panic disorder, it
typically averages 12 hours of face-to-face treatment with a
mental health specialist [25]. Furthermore, there are major
barriers to accessing expert assistance, including a scarcity of
skilled therapists, long waiting lists, high cost, illness symptoms,
comorbid conditions, sociodemographic factors, psychological
distress, and consumer fears regarding the stigma of a mental
health referral [26,27]. These barriers particularly disadvantage
people in regional and rural areas where travelling time and
distance are an added burden [28].
Internet-based treatments largely address all of these barriers,
and, indeed, panic disorder has been effectively treated via the
Internet in a number of countries including Sweden [29-31] and
the United Kingdom [32]. In Australia, one Internet program
for panic disorder, Panic Online (PO), has been developed and
extensively evaluated over the past decade.
Panic Online
Clinical trials have shown that PO, when paired with human
support via email (provided by psychologist), is clinically
superior to information-only control conditions or other forms
of manual and telephone-based therapy [33,34]. PO has also
been found to be credible and satisfying to participants [34],
and outcomes are unaffected by level of education [35].
Furthermore, a recent exploratory study indicated that PO has
the potential to be highly cost-effective [36]. Additionally, PO
was recognized by the National Institute of Clinical Studies
[37], and notably in a recent meta-analysis, it attained the largest
effect size for an Internet-based treatment for a clinical mental
health disorder [38].
To our knowledge, PO has not previously been trialled with
professional support beyond that of a psychologist, except our
own study [39]. This paper reports on the full dataset from a
study for which preliminary findings from a limited dataset have
been published previously [39]. Given the central role that GPs
have in the health system, the aim of the present study was to
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extend our current understanding of PO’s efficacy by examining
participant outcomes when the program is supported by a GP
in a traditional face-to-face consultation in comparison to
eTherapist assistance.
Methods
Participants
A total of 193 people registered for the study, and after 97 were
excluded on the basis of inclusion/exclusion criteria, a total of
96 individuals ultimately commenced treatment as part of this
study: 43 were recruited into the PO plus psychologist support
via email (PO+P) group and 53 into the PO plus face-to-face
GP (PO+GP) group.
In total, 132 BOiMHC-trained (CBT-trained) GPs registered to
participate in the study, of which 37 actively referred the 53
PO+GP patients and treated participants as per the standardized
protocol. Seven psychologists (6 females; 1 male) were
employed as eTherapists for the PO+P group and as assessors
for both groups.
Measures
This study utilized three assessment phases (pretreatment,
posttreatment, and 6-month follow-up after treatment). Each
assessment included a clinical interview conducted over the
telephone by a psychologist and the completion of a set of
self-administered questionnaires accessed via the Internet.
Recent studies have shown that the majority of validated
paper-and-pencil questionnaires generally retain their
psychometric qualities and produce equivalent results when
administered in an online format [40,41].
Anxiety Disorders Interview Schedule-IV
The Anxiety Disorders Interview Schedule-IV (ADIS-IV) is a
semistructured clinical interview designed to permit differential
diagnosis among anxiety and mood disorders and to screen for
other major disorders (eg, substance abuse, psychosis,
somatoform disorders). It includes the “number of panic attacks
in the last month” (PAMTH). The ADIS-IV has
good-to-excellent reliability and validity [42]. In the present
study, the ADIS-IV was used to determine eligibility and
participant diagnosis at each assessment phase.
Anxiety Sensitivity Profile
The Anxiety Sensitivity Profile (ASP) [43] is a 60-item
questionnaire measuring the extent to which respondents are
fearful that anxiety-related sensations will have harmful
consequences. Respondents rate, on a 7-point Likert scale, the
extent to which they agree that the sensations described would
lead to a bad outcome. The ASP has high test-retest reliability
[43].
Depression Anxiety Stress Scale
The Depression Anxiety Stress Scale (DASS) [44] is composed
of three 14-item subscales measuring depression, anxiety, and
stress. The extent to which a variety of symptoms were
experienced within the prior week is rated on a 4-point Likert
scale. Alpha coefficients have been reported at .91, .84, and .90
for the depression, anxiety, and stress subscales, respectively
[44].
Mobility Inventory
The Mobility Inventory (MI) [45] is a measure of agoraphobic
avoidance behavior, comprising 27 items. Participants indicate,
on a 5-point Likert scale (1 = never avoid to 5 = always avoid),
the degree to which they avoid a variety of places or situations
when they are alone (MIA) and accompanied (MIB). Acceptable
psychometrics have been reported for the MI [45-48].
Panic Disorder Severity Scale
The Panic Disorder Severity Scale (PDSS) [49] consists of seven
items rated on a 5-point Likert scale (0 = not at all to 4 = most
severe). The PDSS is designed to assess the severity of seven
dimensions of panic disorder (panic attack frequency, panic
attack distress, anticipatory anxiety, agoraphobia fear and
avoidance, interoceptive fear and avoidance, occupational
impairment/interference, and social impairment/interference)
and associated symptoms. The seven items are summed to derive
a total score ranging from 0-28, with higher scores reflecting
greater symptom severity. The PDSS has excellent interrater
reliability and good validity [49].
Treatment Credibility Scale-Modified
The Treatment Credibility Scale-Modified (TCS-M) [50]
measures respondents’ attitudes to the credibility of a nominated
treatment (in this study, either PO+P or PO+GP). Respondents
rate five items on a 10-point scale (0 = not at all to 10 = very
much) with respect to how credible they consider their allocated
treatment to be after having read a brief rationale and description
of the treatment. Higher scores reflect greater levels of perceived
credibility.
World Health Organization Quality of Life-BREF
The World Health Organization Quality of Life-BREF
(WHOQOL-BREF) [51] is a 26-item questionnaire developed
from the original WHOQOL 100-item questionnaire. The
WHOQOL-BREF covers four domains: physical health (eg,
sleep, pain), psychological health (eg, self-esteem,
concentration), social relationships (eg, social support, personal
relationships), and environment (eg, physical safety, financial
resources, recreation).
Procedure
Study Design
The present study employed a natural groups design open to all
Australian residents who met the inclusion criteria (detailed
below). Participants who were referred to the program by their
GP were allocated back to their GP for treatment and were
therefore in the PO+GP group. Participants who self-referred
to the program (eg, found it via Web surfing, word-of-mouth)
were allocated to receive PO supported by an eTherapist and
were therefore in the PO+P group.
Recruitment
The study was advertised to the general public via participating
GPs, Australian mental health websites, and local and national
J Med Internet Res 2008 | vol. 10 | iss. 2 | e14 | p.3http://www.jmir.org/2008/2/e14/
(page number not for citation purposes)
Shandley et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
media. Study volunteers could register their interest on the PO
website.
GPs were recruited in Victoria, South Australia, and New South
Wales via BOiMHC-accredited training programs. Participating
GPs were sent a project information package and subsequently
were contacted by a research officer (either in person or via
telephone) to discuss research protocols, PO program
components, the manner in which PO was to be used, and the
expected role of the GP and patient in the study. Additionally,
regular consultative support was provided by the research officer
throughout the duration of the study.
Inclusion/Exclusion Criteria
To be included in the study, participants were required to be
Australian residents, have computer access, be 18 years or over,
be fluent in English, have a primary diagnosis of panic disorder
(with or without agoraphobia; as determined via the clinical
telephone interview), and to agree not to undertake any other
type of therapy for their panic disorder during the study. The
request to refrain from other treatments did not cover the
follow-up period. At post-assessment, all participants but one
(whose data were removed from the analysis) had refrained
from other treatments, as measured by self-report.
People were excluded if they reported a seizure disorder, stroke,
schizophrenia, hyperthyroidism, organic brain syndrome, heart
condition, or chronic hypertension as these are confounding
variables with independent associations with panic attacks [52].
People were likewise excluded if they had commenced taking
medication in the previous 12 weeks or were not stabilized on
their medication dose since this has the potential to confound
any treatment effects found for PO.
Assessment
Study registrants were contacted by a psychologist who
conducted a screening interview to determine whether they met
the exclusionary criteria. When exclusionary criteria were met,
volunteers were advised of the reason they could not participate
and were referred to alternative services as appropriate. When
exclusionary criteria were not met, an explanatory statement
and consent form were emailed. Upon return of consent, a full
clinical diagnostic assessment was conducted via telephone
using the ADIS-IV, which took, on average, 90 minutes. Our
interrater reliability for this procedure was .93. Following this,
participants completed a set of online questionnaires. Upon
assessment completion, participants were emailed a username
and password with instructions on accessing the PO program.
Posttreatment and follow-up assessments (clinical telephone
interview and online questionnaires) were conducted at the end
of week 12 and 6 months later. Psychologists did not provide
therapy for any participant they assessed.
The Panic Online Program
PO is a 12-week eTherapy program consisting of an introductory
module, four learning modules, and a relapse prevention module.
The program includes treatment methods commonly used in
standard CBT for panic disorder, including instructions for
controlled breathing, progressive muscle relaxation, cognitive
restructuring, and interoceptive and situational exposure.
Downloadable audio of isometric and progressive muscle
relaxation and sequential photographic slide shows for two
graduated exposure in vivo exercises (going to the supermarket
and driving a car) were provided. An adjunct stress management
program was also available to all participants (see Richards et
al [34]). Information and guidance throughout the program were
standardized across participants.
Panic Online With Psychologists (PO+P)
Communication between participants and psychologists occurred
via email. No limitations were placed on email frequency;
however, the assigned eTherapist was instructed to initiate
contact if he or she had not received communication from a
participant for approximately 1-2 weeks. On average, per
participant, eTherapists sent 15.29 emails (SD 9.26; n = 31) and
spent 378.62 minutes (SD 264.43; n = 29) emailing participants
throughout the 12-week treatment. On average, each eTherapist
provided support to 7.17 (range 2-19) participants.
Panic Online With General Practitioners (PO+GP)
Following assessment by a psychologist, participants allocated
to the PO+GP condition were asked to make an appointment
with their GP for their first PO consultation. The GP was then
informed by the assessor that the patient could commence
treatment. GPs and participants were encouraged to consult
regularly (approximately once per week) throughout the
treatment duration, while participants were using PO between
consultations. On average, participants saw their GP (in a
face-to-face consultation) 7.14 times (n = 31) throughout the
12-week treatment.
Statistical Methods
An independent groups t test was conducted to assess treatment
credibility. Three repeated measures multivariate analysis of
variance (MANOVA), an analysis of covariance (ANCOVA),
and an independent groups t test were performed to analyze
data from this study. MANOVA was conducted to reduce the
possibility of type II errors. The first repeated measures
MANOVA examined panic symptoms and included the
following: clinician-rated panic disorder and agoraphobia
severity (as indicated by the ADIS-IV), PAMTH, ASP, and
PDSS scores. The second MANOVA examined negative affect
and included the three DASS subscales of depression, anxiety,
and stress. The final MANOVA examined quality of life and
included three of the four WHOQOL-BREF domains (physical,
social, and environmental). Lastly, an ANCOVA was conducted
to analyze the WHOQOL-BREF psychological domain using
the pretreatment assessment score as the covariate. This was
analyzed separately as there was a significant difference in the
pre-assessment treatment scores between the two groups.
Results
Participant Characteristics
In addition to their primary diagnosis of panic disorder, 75
participants were also assessed with clinical levels of
agoraphobia (30 in the PO+P group and 45 in the PO+GP
group). See Table 1 for a summary of participant characteristics.
At pretreatment assessment, 52% of participants were taking
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medication (19 in the PO+P group and 31 in the PO+GP group).
Table 2 provides a breakdown of medication frequencies at
pretreatment assessment. Over half of the sample (n = 56)
received a secondary clinical diagnosis at pretreatment
assessment. Table 3 provides a breakdown of the frequencies
of clinically significant comorbid conditions at pretreatment.
Table 1. Characteristics of participants at pretreatment assessment, by group
TotalPO+GPPO+P
SDMeanNo.SDMeanNo.SDMeanNo.Characteristic
11.840.910.938.712.443.5Age (years)
2.812.82.812.92.812.7Education (years)
Gender
201010   Male
764333   Female
Medication
503119   Yes
462224   No
Primary diagnosis
21813   Panic disorder
754530   Panic disorder with agoraphobia
Clinically comorbid condition at pretreat-
ment assessment
563422   Yes
401921   No
Previous mental health treatment (inpa-
tient/outpatient)
492920   Yes
472423   No
Table 2. Medication frequencies at pretreatment assessment, by group
TotalPO+GPPO+PDrug Class*
15141SSRI
1349Benzodiazepine
725SNRI
642SSRI + Benzodiazepine
321Tricyclic antidepressant
1–1Tricyclic antidepressant + SSRI
11–SSRI + SNRI
11–Benzodiazepine + SSRI + Antipsychotic
11–SSRI + Antipsychotic
11–RIMA + Benzodiazepine
11–Anticonvulsant + Benzodiazepine + Antipsychotic
503119Total
*SSRI, selective serotonin reuptake inhibitor; SNRI, selective noradrenaline reuptake inhibitor; RIMA, reversible inhibitor of monoamine oxidase type
A
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Table 3. Clinical comorbid condition frequencies at pretreatment assessment, by group*
TotalPO+GPPO+PDisorder
22175Generalized anxiety disorder
22139Depression
20155Social anxiety disorder
1899Specific disorder
1394Dysthymia
761   Posttraumatic stress disorder
642Hypochondriasis
44–Obsessive compulsive disorder
321Alcohol dependence
11–Substance abuse
*Some participants were assessed as having multiple clinical comorbid conditions.
Attrition
Attrition was defined as participants who withdrew, for reasons
either known or unknown, from the research trial. The overall
attrition rate for this study was 42.7% (41/96): 37.2% (16/43)
and 47.2% (25/53) for the PO+P and PO+GP groups,
respectively. This difference was not significant (χ21 = .60, P =
.41, N = 96). Attrition from the treatment and follow-up phase
was also examined separately. Overall attrition from
pretreatment to posttreatment was 28.1% (27/96), with 16.3%
(7/43) dropping out of the PO+P group and 37.7% (20/53) from
the PO+GP group. Fisher exact test revealed that significantly
more participants in the PO+GP group dropped out of the
treatment (χ21 = 4.40, P = .02, N = 96). A further 14 participants
(14.6%) were lost from the study between posttreatment and
follow-up assessment. The overall attrition rate from
posttreatment to follow-up by condition was 20.9% (9/43) for
the PO+P group and 9.4% (5/53) for the PO+GP group; this
difference was not significant (χ21 = 1.68, P = .15, N = 96).
Table 4 provides reasons for attrition.
Table 4. Reasons for attrition, by group
TotalPO+GPPO+PReason
1899Unknown
541Lost contact
321Commencing face-to-face counselling
321Computer problems
312Personal issues (nonspecific)
22GP difficulties
11Cured
11Health problem
11Housing crisis
11Language difficulties
11Moved state
11Personal issues (mental health)
11Pregnancy
412516Total
Data Properties and Treatment
This study utilized intention-to-treat analyses. That is,
pretreatment assessment scores for participants discontinuing
their involvement during treatment were carried forward and
used in both the posttreatment and follow-up assessments (11
for the PO+P group; 21 for the PO+GP group). Fisher exact test
revealed no difference between the groups (χ21 = 1.52, P = .19,
N = 96). A further 16 PO+P and 13 PO+GP posttreatment
assessment scores were carried forward and used in the
follow-up assessment. The difference was not significant (χ21
= 1.26, P = .19, N = 96).
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Nonnormally distributed dependent variables were transformed
to satisfy normality assumptions. The DASS depression subscale
and the MIA required a square root transformation, and PAMTH
required a logarithmic transformation.
One-way analysis of variance (ANOVA) tests were conducted
on all measures to test for pretreatment differences between
groups. A significant pretreatment difference was found in the
WHOQOL-BREF psychological domain, with the PO+P group
reporting greater quality of life for this domain in comparison
to the PO+GP group (Table 5 and Table 6). However, no
differences were found between the treatment groups for any
other measure (see Table 5). Furthermore, no significant
pretreatment assessment differences were detected for age (F1,94
= 4.09, P = .05), gender (χ21 = .08, P = .62, N = 96),
agoraphobia (χ21 = 2.36, P = .09, N = 96), medication use (χ
2
1
= 1.42, P = .22, N = 96), presence of clinically significant
comorbid condition (χ21 = 1.16, P = .22, N = 96), years of
education (F1,81 = .10, P = .75), or previous inpatient or
outpatient treatment for a mental health condition (χ21 = .35, P
= .54, N = 96).
Results of evaluation of normality assumptions, homogeneity
of variance-covariance matrices, and linearity were satisfactory.
Additionally, Bartlett’s test of sphericity was conducted to
confirm that the dependent variables in the MANOVA groupings
were correlated at the P < .05 level. A multivariate outlier was
detected in the panic symptoms MANOVA grouping and was
subsequently removed due to its impact on the mean.
Table 5. F ratios and P values from pretreatment assessment ANOVA
PFVariable*
.122.521,89DASS depression
.400.721,89DASS anxiety
.211.601,89DASS stress
.063.611,87WHOQOL-BREF physical
.026.091,87WHOQOL-BREF psychological
.171.941,87WHOQOL-BREF social
.102.731,87WHOQOL-BREF environmental
.530.411,84MIA
.580.311,83MIB
.540.381,94PAMTH
.860.031,88ASP
.191.751,86PDSS
*DASS, Depression Anxiety Stress Scale; WHOQOL-BREF, World Health Organization Quality of Life-BREF; MIA, Mobility Inventory alone; MIB,
Mobility Inventory accompanied; PAMTH, panic attacks in the last month; ASP, Anxiety Sensitivity Profile; PDSS, Panic Disorder Severity Scale.
Treatment Outcomes
Treatment Credibility
An independent samples t test revealed no significant differences
between the groups for perceived treatment credibility prior to
treatment (t82 = 1.96, P = .05).
Panic Symptoms
For the panic symptoms grouping, repeated measures MANOVA
revealed no significant interaction between time (pre, post,
follow-up) and group (PO+P, PO+GP) or group main effect.
However, a significant main effect for time was found from
pretreatment to posttreatment assessment. Examination of the
univariate tests for time and associated means revealed a
significant decrease on all seven measures. Means and standard
deviations are presented in Table 6, multivariate results in Table
7, and univariate results in Table 8.
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Table 6. Means and standard deviations for treatment outcome measures at pretreatment, posttreatment, and follow-up treatment assessments, by group
PO+GPPO+P
SDMeanNo.SDMeanNo.Variable*
Clinician panic disorder rating
1.296.29531.256.1743   Pre
2.304.29532.033.4343   Post
2.653.84532.423.0243   Follow-up
Clinician agoraphobia rating
2.355.13532.804.0743   Pre
2.523.65532.222.1643   Post
2.693.40532.342.4043   Follow-up
PAMTH
14.839.85537.996.3343   Pre
8.124.27535.482.6742   Post
7.934.35532.981.8642   Follow-up
PDSS
5.4516.05504.4014.6238   Pre
6.2412.00525.659.7138   Post
6.3611.73505.969.5938   Follow-up
ASP
1.423.40511.313.4539   Pre
1.622.58511.641.8841   Post
1.592.50521.611.8341   Follow-up
MIA
.882.2645.932.1541   Pre
.912.1140.871.7839   Post
.872.0344.881.7637   Follow-up
MIB
.952.67441.092.5541   Pre
.952.36421.082.1439   Post
.932.34451.122.1637   Follow-up
DASS depression
12.8616.45509.8312.2441   Pre
12.9013.52519.767.1540   Post
12.5412.33509.487.2441   Follow-up
DASS anxiety
9.8019.245010.1017.4641   Pre
10.6014.565110.7310.2840   Post
10.4313.645010.3310.2341   Follow-up
DASS stress
10.0621.985010.3519.2641   Pre
11.7917.245110.8412.2340   Post
11.5116.245010.9712.5941   Follow-up
WHOQOL-BREF physical
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PO+GPPO+P
SDMeanNo.SDMeanNo.Variable*
19.6051.594916.8159.0540   Pre
21.1358.545013.8569.5337   Post
20.9457.924814.0870.4338   Follow-up
WHOQOL-BREF psychological
17.7641.074918.0550.4840   Pre
18.4849.835017.9460.4737   Post
19.7548.834817.4560.9638   Follow-up
WHOQOL-BREF social
27.2147.194925.0955.0040   Pre
27.1252.175022.8561.4937   Post
27.6450.614822.8761.1838   Follow-up
WHOQOL-BREF environment
15.7657.654916.9263.3840   Pre
15.7660.585015.0167.0037   Post
15.2760.444815.7667.6238   Follow-up
Treatment credibility
7.0237.47457.5740.5939   Pre
*PAMTH, panic attacks in the last month; PDSS, Panic Disorder Severity Scale; ASP = Anxiety Sensitivity Profile; MIA, Mobility Inventory alone;
MIB, Mobility Inventory accompanied; DASS, Depression Anxiety Stress Scale; WHOQOL-BREF, World Health Organization Quality of Life-BREF.
Table 7. Effects from the repeated measures MANOVA and ANCOVA analysis between groups*
Treatment × TimeGroup EffectTime Effect
β − 1Partial η2PFβ −
1
Partial
η2
PFβ − 1Partial
η2
PFVariable
Panic symptoms
.45.14.351.167,52.62.18.141.657,521.00.58.0010.287,52   Post
.34.10.53.877,58.35.10.52.907,58.77.21.052.167,58   Follow-up
Negative affect
.22.03.50.803,86.42.06.481.693,861.0.39.0018.043,86   Post
.30.04.331.153,86.52.07.10.533,86.16.02.66.533,86   Follow-up
Quality of life
.26.04.41.983,82.49.07.131.953,821.00.36.0015.403,82   Post
.05.001.00.013,80.68.10.042.973,80.17.02.63.583,80   Follow-up
WHOQOL-BREF psychological
.31.03.152.161,83   Post
.08.23.63.231,80.39.04.092.891,80.05.00.95.001,80   Follow-up
*Panic symptoms MANOVA includes clinician-rated panic disorder and agoraphobia severity, PDSS, and PAMTH; negative affect MANOVA includes
DASS subscales of depression, anxiety, and stress; quality of life MANOVA includes WHOQOL-BREF physical, social, and environmental domains.
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Table 8. Effects from univariate tests
Group EffectTime Effect
β − 1Partial
η2
PFβ − 1Partial
η2
PFVariable
Pretreatment to Posttreatment
1.00.55.0069.491,58Panic disorder
1.00.34.0029.911,58PAMTH
1.00.46.0035.371,58ASP
1.00.46.0050.141,58PDSS
1.00.39.0037.231,58Agoraphobia
.97.21.0015.161,58MIA
1.00.27.0021.791,58MIB
1.00.32.0041.181,88DASS depression
1.00.35.0047.981,88DASS anxiety
1.00.34.0044.661,88DASS stress
1.00.35.0045.911,84WHOQOL-BREF physical
.88.11.009.981,84WHOQOL-BREF social
.93.13.0012.071,84WHOQOL-BREF environmental
Posttreatment to Follow-Up
.851.00.009.131,82WHOQOL-BREF physical
.55.05.044.411,82WHOQOL-BREF environmental
*PAMTH, panic attacks in the last month; ASP, Anxiety Sensitivity Profile; PDSS, Panic Disorder Severity Scale; MIA, Mobility Inventory alone;
MIB, Mobility Inventory accompanied; DASS, Depression Anxiety Stress Scale; WHOQOL-BREF, World Health Organization Quality of Life-BREF.
Negative Affect
For the negative affect grouping, repeated measures MANOVA
revealed no significant interaction between time and group or
group main effect. However, a significant main effect for time
was found from pretreatment to post treatment assessment (see
Table 7). Examination of the univariate tests for time (see Table
8) and associated means (see Table 6) revealed a significant
decrease on all three DASS subscales.
Quality of Life
For the quality of life grouping, repeated measures MANOVA
revealed no significant interaction between time and group.
However, a significant main effect for time from pretreatment
to posttreatment assessment and a significant main effect for
group from posttreatment to follow-up assessment were found
(see Table 7). Examination of the univariate tests for time (see
Table 8) and associated means (see Table 6) revealed a
significant positive change on all three domains from
pretreatment to posttreatment. Examination of the univariate
between-subject effects from posttreatment to follow-up revealed
a significant difference between the groups for the
WHOQOL-BREF physical and environmental domains. The
mean scores for both domains (see Table 6) showed that the
PO+P group experienced a slight improvement, whereas the
PO+GP group showed a slight decrease from posttreatment to
follow-up.
WHOQOL-BREF (Psychological)
An ANCOVA was conducted on the psychological domain of
the WHOQOL-BREF from pretreatment to posttreatment and
posttreatment to follow-up. No significant differences were
detected (see Table 7).
Panic-Free Status and High-End State Functioning
Panic-free status and high-end state functioning were examined
at posttreatment and follow-up assessment. Panic-free status
was defined as zero panic attacks reported during the month
immediately prior to the assessment. At posttreatment
assessment, panic-free status was achieved by 52.4% (22/42)
of the PO+P group and 50.9% (27/53) of the PO+GP group;
this difference was not significant (χ21 = .00, P = 1.00, N = 95).
At follow-up, 52.4% (22/42) of the PO+P group and 47.2%
(25/53) of the PO+GP group were panic free, but this difference
was also not significant (χ21 = .09, P = .68, N = 95).
High-end state functioning was defined as being panic free and
having a clinician-rated panic disorder score ≤ 2. At
posttreatment assessment, 28.6% (12/42) of the PO+P group
and 26.4% (14/53) of the PO+GP group achieved high-end state
functioning, but this difference was not statistically significant
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(χ21 = .00, P = .82, N = 95). At follow-up, 47.6% (20/42) of the
PO+P group and 32.1% (17/53) of the PO+GP group achieved
high-end state functioning, but again, the difference was not
significant (χ21 = 1.77, P = .14, N = 95). However, for the PO+P
group, the increase in high-end state functioning from
posttreatment to follow-up was significant (t41 = −2.44, P =
.02).
Discussion
The purpose of the current study was to investigate whether the
established efficacy of PO was affected by changing the form
of therapist assistance from email support provided by
psychologists (eTherapists) to face-to-face support provided by
GPs, and, further, whether treatment improvements were
maintained. The results of this study support findings from
several previous studies examining Internet programs in primary
care [53,54] and demonstrate that evidence-based eTherapy
programs could be a valuable tool for GPs managing patients
with mental health conditions.
The recommended treatment for panic disorder includes CBT,
medication (antidepressants and/or benzodiazepines), or a
combination of both [55]. However, there are difficulties
associated with each form of treatment. Barriers such as
accessibility, waiting lists, cost, and stigma inhibit access to
CBT experts [26,27], and use of pharmacotherapy is often
complicated by side effects, compliance, and other health
considerations [56]. Furthermore, medication use in comparison
to CBT treatment does not appear to result in sustained recovery
beyond discontinuation [56,57]. Consequently, investigating
other methods of delivering cost-effective and clinically effective
treatment is important to address the growth of mental health
disorders both in general practice and the wider community.
In this study, PO (whether supported by eTherapists or
face-to-face GPs) led to significant improvements in panic attack
frequency, depression, anxiety, stress, anxiety sensitivity,
agoraphobia avoidance, and quality of life. Improvements were
maintained at follow-up, with the only significant differences
occurring on the WHOQOL-BREF physical and environmental
domains. It is beyond the capacity of this study to ascertain
definitively why the groups differed on these particular
measures. It is possible to speculate, however, that the different
dissemination processes (email vs face-to-face) created disparate
learning experiences between the groups, resulting in the PO
treatment information being used and retained in different
manners. Further, while the groups did not significantly differ
on any pretreatment assessment sociodemographic measure,
the PO+GP group did have a higher degree of comorbidity and
proportion of participants on medication. Consequently, it is
possible that this study inherently measured two different
cohorts.
Surprisingly, attrition from treatment was significantly higher
for the PO+GP group. A number of possible reasons can be
hypothesized. First, there was variation in the level of support
throughout the duration of the trial. While participants in the
PO+GP group were encouraged to regularly access their GP
throughout treatment, this was not a requirement, and GP
visitations could not be reasonably regulated within this study.
By contrast, participants in the PO+P group were able to email
their therapist as often as they wished, and their therapist was
required to respond within 24 hours. Second, greater effort and
planning are required to attend a medical practice in comparison
to writing an email. Consequently, participants in the PO+P
group may have experienced a greater level of continuous
support and encouragement to adhere to the treatment. It is also
worth noting that while treatment credibility was not
significantly different between the groups, it did near
significance, with the PO+P treatment appearing to be viewed
more favorably than the PO+GP treatment. Finally, it is not
known whether the content of GP visits focused specifically on
panic disorder or incorporated consultation on other unrelated
ailments. However, in comparison to other Internet-based studies
[14,16], attrition overall in this study was relatively low.
It is noteworthy that the proportion of participants achieving
high-end state functioning in both groups continued to increase
from posttreatment to follow-up and that for the PO+P group,
the increase was significant. These results not only support the
durability of PO to maintain treatment outcomes but also
indicate that it has the capacity to continue to have benefits
beyond treatment completion.
Limitations
There are several methodological issues and limitations to note.
The primary limitation of this study was that it used a
nonrandomized, natural groups design. Consequently, we can
not speak to the direct comparability of these two treatments,
and it is possible that the groups differed in ways not considered
within this study. It should also be mentioned that all
participating GPs were trained in delivering CBT. It is unknown
whether non-CBT-trained GPs would achieve similar outcomes.
This issue would benefit from further investigation as the
accessibility to the program would be increased substantially if
the evidence base indicated that all GPs were able to effectively
support patients using the program. As discussed earlier, the
treatments differed in terms of the supportive communication
modality employed. This factor may have affected attrition and
was not investigated. A final issue relates to PO access.
Unfortunately, participant usage statistics (eg, number of times
accessed PO, duration of time spent on PO) were not available.
Consequently, it is possible that one group may have spent a
proportionally greater period of time accessing and/or reading
the PO material and therefore achieved and sustained greater
benefits.
Implications
A number of implications for policy and practice can be derived
from this study. While it is anticipated that there might be
reluctance to adopt eTherapy into general practice [58], this
study has demonstrated the capacity of evidence-based
programs, such as PO, to aid GPs in the management of mental
health disorders, such as panic disorder, and achieve sustained
outcomes, making them an invaluable tool. However, at present,
there is no specific Medicare and/or private health insurance
rebates on such services. Furthermore, there is need for
appropriate educational and financial support within primary
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care to integrate these programs within existing public health
systems.
Conclusions
This study demonstrates that when panic disorder sufferers are
provided with accessible online treatment protocols, CBT-skilled
GPs can achieve sustained patient outcomes comparable to
best-practice treatments delivered by psychologists. Further
research will be required to evaluate Internet-based programs
for other mental health conditions and with non-CBT-trained
GPs. Nevertheless, this study provides strong evidence that the
use of Internet-based programs is an effective adjunct to existing
mental health care services and may enable the delivery of
evidence-based treatments to increasingly large numbers of
patients via primary care with the support of suitably trained
health professionals.
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